<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0278996" disease_type="Neoplastic Process" abbrv="">Head and neck cancers</z:e> display diverse patterns of biological behavior and considerable variation in geographical distribution </plain></SENT>
<SENT sid="1" pm="."><plain>This study presents an analysis of <z:e sem="disease" ids="C0278996" disease_type="Neoplastic Process" abbrv="">head and neck cancer</z:e> in a Nigerian tertiary healthcare center </plain></SENT>
<SENT sid="2" pm="."><plain>It comprises cases diagnosed at the University College Hospital, Ibadan, Nigeria, 1991-2005 </plain></SENT>
<SENT sid="3" pm="."><plain>Out of 1,750 head and <z:e sem="disease" ids="C0027533" disease_type="Neoplastic Process" abbrv="">neck tumors</z:e>, 972 (55.5%) were malignant and 778 (44.5%) were benign </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancers</z:e> displayed male predominance, with a gender ratio of 1.8:1 </plain></SENT>
<SENT sid="5" pm="."><plain>The mean age of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients was 43.8 +/- 19.6 years </plain></SENT>
<SENT sid="6" pm="."><plain><z:mp ids='MP_0002038'>Carcinomas</z:mp> constituted 71.7% of <z:e sem="disease" ids="C0278996" disease_type="Neoplastic Process" abbrv="">head and neck cancers</z:e>, with 2.4% occurring in children and overall mean age of 48.2 years </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0002860'>Squamous cell carcinoma</z:hpo> comprised 66.7% of <z:mp ids='MP_0002038'>carcinomas</z:mp> and 47.8% of <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C0278996" disease_type="Neoplastic Process" abbrv="">head and neck cancers</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain><z:e sem="disease" ids="C0376544" disease_type="Neoplastic Process" abbrv="">Hematopoietic malignancies</z:e> constituted 20.4% of <z:e sem="disease" ids="C0278996" disease_type="Neoplastic Process" abbrv="">head and neck cancers</z:e>, and comprised mainly <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, which accounted for 19.3% of <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C0278996" disease_type="Neoplastic Process" abbrv="">head and neck cancers</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>The mean age of patients with <z:e sem="disease" ids="C0376544" disease_type="Neoplastic Process" abbrv="">hematopoietic malignancies</z:e> was 34.9 years </plain></SENT>
<SENT sid="10" pm="."><plain>The most common childhood <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> was Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, which comprised 28.2% of pediatric <z:e sem="disease" ids="C0278996" disease_type="Neoplastic Process" abbrv="">head and neck cancers</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>Connective tissue <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> constituted 7.9% of <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, the most common being <z:hpo ids='HP_0002859'>rhabdomyosarcoma</z:hpo>, accounting for 44.2% of <z:hpo ids='HP_0100242'>sarcomas</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>The mean age of patients with <z:hpo ids='HP_0100242'>sarcomas</z:hpo> was 26.5 years </plain></SENT>
<SENT sid="13" pm="."><plain>There is a need for uniformity in the definition of <z:e sem="disease" ids="C0278996" disease_type="Neoplastic Process" abbrv="">head and neck cancer</z:e> so as to permit comparison of international studies </plain></SENT>
<SENT sid="14" pm="."><plain>In addition, prospective population-based studies are required to determine the national incidence and to identify risk factors for <z:e sem="disease" ids="C0278996" disease_type="Neoplastic Process" abbrv="">head and neck cancer</z:e> in the Nigerian population </plain></SENT>
</text></document>